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Behavioral/Cognitive

A GABAergic Projection from the Centromedial Nuclei of the
Amygdala to Ventromedial Prefrontal Cortex Modulates
Reward Behavior
X Dong-oh Seo,1* X Samuel C. Funderburk,1,4* X Dionnet L. Bhatti,1 Laura E. Motard,1 X Dillan Newbold,1
Kasey S. Girven,5 Jordan G. McCall,1 Michael Krashes,4 Dennis R. Sparta,5 and XMichael R. Bruchas1,2,3
1Department of Anesthesiology, Division of Basic Research, 2Department of Neuroscience, and 3Pain Center, Washington University School of Medicine,
St. Louis, Missouri 63110, 4Diabetes, Endocrinology and Obesity Branch, National Institutes of Diabetes and Digestive and Kidney Diseases, National
Institutes of Health, Bethesda, Maryland 20892, and 5Department of Anatomy and Neurobiology, University of Maryland School of Medicine, Baltimore,
Maryland 21201

The neural circuitry underlying mammalian reward behaviors involves several distinct nuclei throughout the brain. It is widely accepted
that the midbrain dopamine (DA) neurons are critical for the reward-related behaviors. Recent studies have shown that the centromedial
nucleus of the amygdala (CeMA) has a distinct role in regulating reward-related behaviors. However, the CeMA and ventromedial PFC
(vmPFC) interaction in reward regulation remains poorly understood. Here, we identify and dissect a GABAergic projection that originates in the CeMA and terminates in the vmPFC (VGat-Cre CeMA-vmPFC) using viral-vector-mediated, cell-type-specific optogenetic techniques in mice. Pathway-specific optogenetic activation of the VGat-Cre CeMA-vmPFC circuit in awake, behaving animals produced a
positive, reward-like phenotype in real-time place preference and increased locomotor activity in open-field testing. In sucrose operant
conditioning, the photoactivation of these terminals increased nose-poking effort with no effect on licking behavior and robustly facilitated the extinction of operant behavior. However, photoactivation of these terminals did not induce self-stimulation in the absence of an
external reward. The results described here suggest that the VGat-Cre CeMA-vmPFC projection acts to modulate existing reward-related
behaviors.
Key words: amygdala; CEA; MEA; reward; vGat; vmPFC

Significance Statement
Many studies have shown that the interactions between the centromedial nucleus of the amygdala (CeMA) and ventromedial PFC
(vmPFC) have critical roles for emotional regulation. However, most studies have associated this circuit with fear and anxiety
behaviors and emphasized top-down processing from vmPFC to CeMA. Here, we provide new evidence for bottom-up CeMA to
vmPFC influence on reward-related behaviors. Although previous work implicated the CeMA in incentive salience, our results
isolate the investigation to a specific CeMA GABAergic projection to the vmPFC. This long-range GABAergic interaction between
amygdala and frontal cortex adds a new dimension to the complex regulation of reward-related behaviors.

To survive in complex and changing environments, animals must
actively attend to salient stimuli and seek out potential rewards

(Hikosaka et al., 2008). In mammals, dynamic network interaction between subcortical [e.g., nucleus accumbens (NA), ventral
tegmental area (VTA), and amygdala] and cortical neural struc-
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tures (e.g., medial PFC and orbitofrontal cortex) modulates reward value representation (Kelley and Berridge, 2002; Patton et
al., 2013; Richard and Berridge, 2013; Ferenczi et al., 2016), allowing animals to respond appropriately to events. Dysregulation of this process has been implicated in the development of
psychiatric disorders such as depression and drug addiction
(Gorwood, 2008; Ferenczi et al., 2016).
The amygdala is an important hub for processing emotional
information in both aversive and appetitive circumstances (LeDoux, 1993; Baxter and Murray, 2002; Paré et al., 2004; Lee et al.,
2010; Stuber et al., 2011; Stuber et al., 2011; Li et al., 2015; Namburi et al., 2015). The amygdala is structurally diverse and mainly
divided into the basolateral nuclei group (BLA) and centromedial
nuclei group (CeMA) that includes the central (CeA) and medial
(MeA) nucleus of the amygdala (Sah et al., 2003). Early studies
suggested that the BLA encoded reward value in reward-directed
behaviors (Schoenbaum et al., 1998; Baxter and Murray, 2002).
The CeMA is generally considered to be a major group of output
nuclei of the amygdala (LeDoux, 1993; Sah et al., 2003). However,
emerging evidence supports a distinct role for the CeMA in
reward-directed behaviors and food consumption (Parker et al.,
2014; Robinson et al., 2014). Robinson et al. (2014) recently demonstrated that rats trained to press levers for a sucrose reward will
press more frequently when sucrose is paired with concurrent
stimulation of the CeA, suggesting that the CeMA amplifies external reward value.
The amygdala interacts with many neural structures across the
brain, including the ventromedial PFC (vmPFC). The vmPFC
also has reciprocal connectivity with the amygdala (McDonald,
1987; Jackson and Moghaddam, 2001; Baxter and Murray, 2002;
Likhtik et al., 2005; Sparta et al., 2014) and has been implicated in
behavioral extinction in fear-conditioning paradigms through
inhibition of amygdalar circuits, but recent studies support that
the vmPFC is also a key regulator of the VTA and NA, subcortical
neural structures involved in goal-directed behavior and reward
valuation (Jackson and Moghaddam, 2001; Peters et al., 2009;
Patton et al., 2013). Previous studies have documented anatomical connections between the vmPFC and the BLA, the basomedial nucleus of amygdala, and the intercalated cells, supporting a
top-down control mechanism (Peters et al., 2009; Cho et al.,
2013; Adhikari et al., 2015). However, direct connections between the CeMA and vmPFC supporting a bottom-up control
mechanism and its function has not been described.
Here, we describe a novel GABAergic projection from the
CeMA to the vmPFC using cell-type-specific optogenetic techniques. Using adeno-associated virus (AAV)-mediated gene
transfer to transduce the CeMA with the light-gated ion channel,
channelrhodopsin-2 (AAV5-EF1␣-DIO-ChR2-eYFP), we selectively targeted the inhibitory projection neurons of the CeA and
dorsal part of MeA (CeMA) using VGat mice (VGat CeMA-Cre)
and stimulated the vmPFC region to isolate the GABAergic
CeMA-vmPFC (VGat CeMA-vmPFC) circuit. We first assessed
whether this VGat CeMA-vmPFC circuit is involved in modulating
emotional valence and general locomotor activity. We then explored its function in reward-seeking behavior using a sucrose
reward operant conditioning paradigm. Our study revealed that
the inhibitory projection from the CeMA to the vmPFC is specifically involved in the amplification of an external reward value, as
well as modulation of extinction in sucrose operant conditioning.

Materials and Methods
Subjects. Group-housed adult (25–35 g) male VGat-IRES-Cre mice
(RRID:IMSR_JAX:016962) and Cre(⫺) littermate controls were used for
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projection mapping and all in vivo experiments (Vong et al., 2011). Mice
were given access to food pellets and water ad libitum and maintained on
a 12:12 h light/dark cycle (lights on at 7:00 A.M.). All experimental procedures were approved by the Animal Care and Use Committee of Washington University and conformed to National Institutes of Health
guidelines.
Surgical procedures for viral injection and fiber-optic placement. All surgeries were performed under 4% isoflurane anesthesia (Piramal Healthcare). For initial projection mapping, adult male mice were injected
unilaterally with 500 nl of AAV5-EF1␣-DIO-eYFP virus (WUSTL Hope
Center Viral Core) into the CeA (AP: ⫺1.35 mm, ML: ⫺2.75 mm, DV:
⫺4.5 mm), and CTB into vmPFC (AP: ⫹1.95 mm, ML: ⫹0.25 mm, DV:
⫺2.80). For behavior and physiology experiments, adult male mice were
injected unilaterally with 500 nl of AAV5-EF1␣-DIO-ChR2-eYFP virus
(WUSTL Hope Center Viral Core) into the CeA (AP: ⫺1.35 mm, ML:
⫺2.75 mm, DV: ⫺4.5 mm) (Cai et al., 2014; McCall et al., 2015). The
CeA was targeted carefully and viral volumes were limited accordingly,
although there was expression in the MeA at times due to the use of a
vGAT-IRE-cre driver mouse; therefore, the target is referred to as centromedial nuclei herein to avoid confusion and to relay information for
future studies. Four to 5 weeks after virus injection, fiber-optic ferrules
were implanted chronically above the infralimbic PFC (AP: ⫹1.78 mm,
ML: ⫺0.3 mm, DV: ⫺2.25 mm) and dental cement (Lang Dental) was
applied to hold the ferrules in place (Sparta et al., 2012). Mice were
allowed to recover for at least 6 weeks after infusion of virus before
further behavioral testing or perfusion for projection mapping to ensure
optimal viral expression.
Patch-clamp electrophysiology. Brain slice preparation and general
methods for patch-clamp electrophysiology were conducted as described
previously (Jennings et al., 2013). To examine CeMA postsynaptic currents evoked by optical stimulation of GABA neurons, 200 m coronal
slices containing the mPFC were prepared from mice expressing ChR2eYFP in CeA GABA neurons. For whole-cell voltage-clamp recordings of
IPSCs from mPFC putative pyramidal neurons, electrodes (2– 4 M⍀
electrode resistance) contained the following (in mM): 130 cesium chloride, 10 HEPES, 1 EGTA, 2 Mg-ATP, and 0.2 Na-GTP, pH 7.2–7.4,
275–285 mOsm. Photostimulation (5 ms pulses of 1–2 mW, 473 nm light
delivery via LED through a 40⫻ microscope objective) was used to stimulate CeA GABA terminals expressing ChR2-eYFP in the mPFC. If mPFC
cells were light responsive, then 10 m gabazine was applied. All cells
were held at ⫺70 mV.
Real-time place preference (RTPP). Mice were placed into a custommade black acrylic two-chambered box (52.5 ⫻ 25.5 ⫻ 25.5 cm) and
allowed to explore each of two chambers for 30 min. Using an Ethovision
hardware controller (Noldus Information Technologies) connected to a
master 9 functional generator, light stimulation (473 nm, ⬃10 mW) at
20, 30, or 60 Hz (10 ms pulse width) was delivered through fiber-optic
implants during the duration of their time spent in the light stimulation
side of the chamber. Mice received no light stimulation on the “no stimulation” side. The experimental animals were counterbalanced for both
group and stimulation side. Preference scores in each experiment were
determined by computing the percentage of time spent in the “light
stimulation” side out of the total explored time during the tests. All
behavioral data, including traveled distance and time, were collected and
analyzed using Ethovision version 9.5 software (Noldus Information
Technologies, RRID:SCR_000441) with a digital camera (ZR900;
Canon) mounted above. Mice that did not cross the threshold between
the two chambers were excluded from analysis.
Open-field test (OFT). Mice were placed into a custom-made white box
(50 cm ⫻ 50 cm) within a sound-attenuated room maintained at ⬃23°C.
Lighting was measured and stabilized at ⬃25 lux. Mice were allowed to
explore the entire chamber freely for 30 min. Using the Ethovision hardware controller connected to a master 9 functional generator, light stimulation (473 nm, ⬃10 mW, 10 ms pulse width) at 20 Hz was delivered
through fiber-optic implants for the duration of the trial. Time spent in
the center of the open field was used as a measure of anxiolysis. All
behavioral tracking data were collected and analyzed using Ethovision
software with the digital camera mounted above.
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Sucrose operant conditioning. All tests took place in mouse operant
chambers (17.8 cm ⫻ 15.2 cm ⫻ 18.4 cm; Med Associates). A rotating
optical commutator (Doric) was located on the top of the operant chamber and connected to a 473 nm diode-pumped solid-state laser (OEM
Laser Systems; see Fig. 3B). Fibers were connected to the implants on the
mouse for every training session. The conditioning chamber light was
turned on during every training session. Laser power was adjusted to
obtain ⬃10 mW transmittance into the brain. Mice were initially food
deprived to 90% body weight and habituated to operant chambers and a
lickometer program for 20 trials of 20 s sipper release with variable interval for 60 min. During the 20 s sipper release period, an orange-colored
cue light turned on above the sipper. Training continued until each
mouse produced at least 300 licks in a session.
FR1 and extinction. Mice were trained to nose poke in a MED Associates operant box with two nose-poke portals available, “active” and “inactive.” Successful nose pokes on the active nose poker rewarded the
mouse with 20 s access to a sipper providing 10% sucrose solution. Operant responses on active portal were reinforced on a fixed ratio 1 (FR1)
schedule. Nose poking to the active portal during the 20 s reward period
and to the inactive portal produced no consequences or rewards. This
procedure was repeated for 8 d for animals to get criteria (reinforcers
⬎25, active lever presses ⬎70%, in the last 3 consecutive days of the FR1
training). For extinction, the experimental setup was the same except
that the active portal was disabled and light stimulation (20 Hz, ⬃10
mW, 10 ms pulse width) was delivered throughout the 60 min session.
Self-stimulation. Successful nose pokes on the active portal were rewarded with 20 s of light stimulation (20 Hz, ⬃10 mW) with the cue light.
An inactive nose poke resulted in neither stimulation nor cue light. This
procedure was repeated for 2 d.
FR3 ⫹ light stimulation. Three successive nose pokes (FR3) to the
active portal rewarded the mouse with 20 s access to a sipper that delivered 10% sucrose solution with concurrent light-stimulation (20 Hz).
Immunohistochemistry. After the conclusion of behavioral testing,
mice were anesthetized with sodium pentobarbital and transcardially
perfused with ice-cold PBS, followed by 4% phosphate-buffered paraformaldehyde. Brains were removed, postfixed overnight in 4% paraformaldehyde, and then saturated in 30% phosphate-buffered sucrose. Next, 30
m sections were cut, washed in 0.3% Triton X-100/5% normal
goat serum in 0.1 M PBS, stained with fluorescent Nissl stain (1:400
Neurotrace; Invitrogen) for 1 h, and mounted onto glass slides with
Vectashield (Vector Laboratories). For immunofluorescence labeling,
sections were incubated in blocking solution (PBS with 5% normal
goat serum and 0.3% Triton X-100) for 1 h with gentle agitation before
incubation with the following primary antibodies: rabbit anti-GAD67
(1:1000) and anti-GAD65 (1:1000, Millipore Cat# AB1511, RRID:
AB_11210186). Sections were incubated with primary antibodies at
room temperature overnight and rinsed for 5 min in 3 changes of PBS.
Secondary antibodies (Alexa Fluor 568-conjugated goat anti-rabbit, Invitrogen Cat# A11011, RRID: AB_2534078) were diluted in PBS (secondary antibodies at 1:1000) with 5% normal goat serum and 0.3% Triton
X-100. Sections were incubated for 2 h at room temperature with gentle
agitation and then rinsed in PBS, mounted, and coverslipped.
Viral ChR2 expression was verified using fluorescence (Olympus) and
confocal (Leica Microsystems) microscopy. Images were produced with
10⫻, 20⫻, 63⫻, 100⫻ objective and analyzed using ImageJ software
(NIH) and Leica Application Suite Advanced Fluorescence software.
Mice that did not show targeted expression were excluded. Fluorescence
intensities are reported separately for the vmPFC, CeA, and dorsal part of
medial nucleus of amygdala (dMeA). The vmPFC axonal terminal fluorescence was measured ⬃1.70 to 1.98 mm relative to bregma and comprised a 3-section series (Paxinos, 2001). CeA fluorescence was measured
⫺0.90 to ⫺1.80 mm and comprised a 3-section series.
Statistical analysis. All data are expressed as mean ⫾ SEM. Behavioral
data were analyzed with JMP12 Pro (SAS Institute, RRID:SCR_014242).
Student’s t test and one-way or two-way ANOVAs were used to analyze
between-subjects designs. Repeated-measures designs were analyzed using a mixed-effects restricted maximum likelihood (REML) model. Least
significant difference was used for post hoc pairwise comparisons. The
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null hypothesis was rejected at the p ⬍ 0.05 level. Statistical significance
was taken as *p ⬍ 0.05, **p ⬍ 0.01, ***p ⬍ 0.001.

Results
Identification of a GABAergic projection from the CeMA to
the vmPFC
The CeMA, which is typically associated with fear and anxiety
behaviors, has recently been identified as a mediator of incentive
motivation (Robinson et al., 2014). However, the incentive
motivation-related downstream circuit is relatively less investigated compared with the circuits in fear and anxiety. The CeMA
contains large populations of GABAergic neurons (Davis et al.,
1994; Sah et al., 2003). Therefore, we explored the GABAergic
projection from CeMA using viral vector-mediated, cell-typespecific florescence tracing techniques.
We expressed the genetically encoded light-sensitive cation
channel (AAV5-EF1␣-DIO-ChR2) in the CeA-vmPFC pathway
under the control of mouse vesicular GABA transporter (VGat)
promoter, which is expressed in inhibitory neurons (GABAergic
and glycinergic neurons; Fig. 1A). Viral tracing revealed a vgat ⫹
nerve bundle that originated in the CeA (Fig. 1B) and terminated
in the vmPFC (Fig. 1C). In the CeA, the virus expressed widely
throughout anterior–posterior axis and almost covered the entire
CeA area, but was not seen in the BLA. This is consistent with the
report that this transgenic mouse line has relatively low level of
Cre activity in the BLA (Vong et al., 2011). The ChR2 virus also
sparsely spread to the dorsal part of the MeA (Fig. 1B); therefore,
for accuracy, we refer to our targeting here as CeMA. This bundle
exited the CeA through a known pathway: the stria terminalis
(images are not shown). Our viral tracing, however, revealed a
subpopulation of axons that continued anteriorly to the frontal
cortex, terminating primarily in the vmPFC including infralimbic PFC (Fig. 1C), medial orbitofrontal cortex, and dorsal peduncle. In particular, relatively dense fluorescence expression was
observed around the medial wall of the vmPFC along the midline
axis. The prelimbic PFC shows a relatively low level of projections. These fluorescently labeled CeMA-vmPFC terminals were
coexpressed with GAD65 ⫹ 67 immunoexpression, which suggests that these terminals are long-range inhibitory terminals
originating from the CeMA (Fig. 1E). For control purposes, we
injected the same type of virus in VGlut-Cre mice, which express
Cre in glutamatergic neurons (Vong et al., 2011). Whereas a
known VGlut ⫹ projection from the BLA to the vmPFC and surrounding regions was identified, there was limited expression of
glutamatergic cells in the CeA (images not shown).
To examine the functional connectivity between CeMA
GABA projection neurons and vmPFC neurons, whole-cell recordings from vmPFC neurons revealed that photostimulation of
ChR2-containing terminals originating from CeMA GABA neurons produced IPSCs and formed functional synapses on neurons within the vmPFC (Fig. 1F–I ). In addition, we found that
application of gabazine completely blocked the eIPSC, indicating
that this projection is GABAergic (Fig. 1 H, I; t(4) ⫽ 3.83, p ⫽
0.019). We also found that the latency to a response was 1.96 ms
upon onset of light stimulation. Furthermore, the time to peak of
the eIPSC was 4.78 ms, suggesting that this projection is monosynaptic. However, we cannot rule out a polysynaptic connection. Together, these data suggest that our methods allowed for
preferential targeting and manipulation of CeMA GABAergic fibers within the vmPFC.
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Figure 1. GABAergic projections from the CeMA to the vmPFC. A, Diagram showing viral delivery into the CeMA of VGat-IRES-cre mouse. B, Representative confocal image of ChR2-eYFP
expression in the CeMA. C, Confocal image showing representative ChR2-eYFP fiber expression in the vmPFC of VGat-IRES-cre mice. Inset shows the high-magnification image. D, Diagram showing
CTB delivery into the vmPFC of a wild-type mouse and CTB expression in the CeMA. E, Representative images of GAD65 ⫹ 67 immunohistochemistry of the eYFP expressing terminals in the vmPFC.
The eYFP-expressing terminals coexpresses with GAD65 ⫹ 67. F, Schematic diagram depicting combined patch-clamp electrophysiological and optogenetic manipulations in the vmPFC. G, vmPFC
patching map. H, Example trace of a light-responsive vmPFC neuron (top) and a light-responsive vmPFC neuron treated with gabazine (bottom). I, photostimulation of ChR2-containing terminals
originating from CeMA GABA neurons produced IPSCs. *p ⬍ 0.05. CeL/CeM/CeC, lateral/medial/capsular subdivisions of the central nucleus of amygdala; IL/PrL, impralimbic/prelimbic PFC. Scale
bars: B, 250 m; C, 100 and 10 m (inset); D, 5 m.

VGat-Cre CeMA-vmPFC terminal photoactivation facilitates
RTPP and increases locomotion
Earlier studies have shown that the amygdala and PFC play important roles in modulating multiple behavioral paradigms with
motivational valence components such as Pavlovian fear conditioning and drug-based operant conditioning (LeDoux, 1993;
Baxter and Murray, 2002; Peters et al., 2009; Nieh et al., 2013).
First, we assessed whether the CeMA to vmPFC GABAergic projections (VGat CeMA-vmPFC) are involved in modulating valence
state using RTPP. Mice were placed into a black acrylic twochambered box for RTPP tests as described previously (AlHasani et al., 2015; McCall et al., 2015; Siuda et al., 2015). To
determine optimal stimulation parameters, we performed a
frequency-response RTPP. Photostimulation was delivered in a
closed loop during travel into the light-paired side at 20, 30, and
60 Hz (10 ms pulse width) each experimental day (Fig. 2 A, B).
In this experiment, the VGat CeMA-vmPFC::ChR2 mice spent significantly more time on the side paired with light-stimulation than
control mice (VGat::Cre- littermates) under all three different stimulation conditions (20 Hz, 30 Hz, and 60 Hz), indicating a preference for light stimulation of the CeMA-vmPFC terminals (Fig. 2C,D;
REML: group, F(1, 23.26) ⫽ 12.41, p ⫽ 0.002; group ⫻ frequency,
F(3, 39.35) ⫽ 3.65, p ⫽ 0.020; the degree of freedom is adjusted; post
hoc, control vs ChR2 at 0 Hz, p ⫽ 0.26, at 20 Hz, p ⫽ 0.03; at 30 and

60 Hz, p ⬍ 0.003). Further analysis of the 20 Hz light-stimulation
data, similar to recent CeA-optogenetic studies with functional relevance to reward-related behavior (Robinson et al., 2014), showed a
significant preference for the light-paired side (Fig. 2C,E; t(21) ⫽ 3.06,
p ⫽ 0.005) without changes in total distance traveled (Fig. 2F; t(21) ⫽
0.63, p ⫽ 0.531).
Next, we investigated whether VGat CeMA-vmPFC::ChR2 activation
drives generalized changes in reward valence and general locomotor
activity. The same group of mice was tested in open field 2 d after RTPP
tests. Upon placement into an empty white box as described previously
(Siuda et al., 2015), the VGat CeMA-vmPFC::ChR2 mice traveled significantly more compared with wild-type control mice (Fig. 2G,H; t(12) ⫽
2.330, p ⫽ 0.0381) at 20 Hz; however, there were no significant changes
inthedistancetraveledinthecenteroftheopenfield(Fig.2I;t(12) ⫽0.95,
p ⫽ 0.358, n.s.), indicating a lack of effect on anxiety-related behaviors.
Together, these results suggest that this GABAergic projection from
CeMA to vmPFC can cause reward-like behaviors and affect general
locomotion, but on its own, it does not affecty general anxiety-like
behavior.
VGat-Cre CeMA-vmPFC::ChR2 terminal light activation is not
sufficient to induce self-stimulation
In the above experiments, activation of the GABAergic projection
from CeMA to vmPFC drove behaviors with positive motivational
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valence and real-time preference. To further assess whether
VGat CeMA-vmPFC photoactivation itself was an independent reward,
we used an operant self-stimulation paradigm in which mice could
self-stimulate with 20 Hz (20 s) photoactivation by nose poke (Fig.
3A,B). Importantly, these mice were pretrained in a sucrose operant
conditioning on an FR1 schedule with 10% sucrose solution
delivery to the sipper before this self-stimulation training
(VGat CeMA-vmPFC::eYFP mice and VGat::Cre ⫺ mice data were combined into a single control group). In the FR1 training, all groups of

mice showed similar level of nose-poking performance for a sucrose
reward, indicating that both groups of mice were able to perform
normal nose-poking behaviors (see Fig. 6C,D). To avoid the compounding effect with the sucrose-associated nose-poke portal, the
previously “inactive” nose-poke portals were used as the “active”
reinforcing nose-poke portal in this experiment (Fig. 3B). Results
showed that the VGat CeMA-vmPFC::ChR2 light stimulation failed to
produce significant self-stimulation (Fig. 3C,D; Fs ⬎ 1, n.s.). These
results do not support that VGat CeMA-vmPFC::ChR2 photoactivation
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has positively reinforcing properties in
the operant setup and suggest that
VGat CeMA-vmPFC::ChR2 photoactivation
does not affect intrinsic motivational states.
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reward was equivalent between both
4A).
In
addition,
a
separate
groups (Fig.
Further analysis comparing these three groups (amplified, nonamcohort of animals was trained on FR1 without exposure to any
plified, and control) using REML analysis revealed that the amplified
other behavioral training such as extinction and self-stimulation.
CeMA-vmPFC
group of mice nose poked significantly more than other groups on
There was no difference between VGat
::ChR2 and
the fourth day, but the increased number of nose pokes in the amcontrol groups in the number of rewards taken (Fig. 4C; t(30) ⫽
plified group of mice was significantly decreased to the nonamplified
⫺0.76, p ⫽ 0.451) or active nose pokes (Fig. 4F; t(30) ⫽ ⫺0.82,
response and control level on the FR3 training day (FR3 ⫹ no light;
p ⫽ 0.414) on day 1 of the FR1 schedule. Starting on day 2, mice
Fig.
4J; REML; responder, F(2,29) ⫽ 11.44, p ⬍ 0.001; session,
were trained on an FR3 schedule for 3 d with concurrent photoCeMA-vmPFC
F
⫽ 3.58, p ⫽ 0.068; group ⫻ session, F(2,29) ⫽ 10.32, p ⬍ 0.001;
(1,29)
4B).
VGat
stimulation in the vmPFC (Fig.
::ChR2
Tukey, light vs no light in the amplified group, p ⫽ 0.001, amplified
mice showed a significantly higher number of rewards received
vs nonamplified; control on the FR3 ⫹ light, p ⬍ 0.001). We could
(Fig. 4D; REML: group, F(1,30.13) ⫽ 6.11, p ⫽ 0.019; day,
not find clear differences in the targeting area of the fiber-optic (Fig.
F(1,59.29) ⫽ 3.10, p ⫽ 0.052; group ⫻ frequency, F(1,59.29) ⫽ 0.71,
eYFP axonal fiber expression in the vmPFC (Fig. 4L: vmPFC,
4K),
p ⫽ 0.495; degree of freedom is adjusted) and active nose pokes
t(13) ⫽ 0.20, p ⫽ 0.844), eYFP expression in the CeA (Fig. 4L: CeA,
(Fig. 4G; REML: group, F(1,30.15) ⫽ 6.29, p ⫽ 0.017; day,
F(1,11) ⫽ 0.93, p ⫽ 0.355; group ⫻ region, F(2,22) ⫽ 1.64, p ⫽ 0.215),
F(1,59.34) ⫽ 2.60, p ⫽ 0.08; group ⫻ frequency, F(1,59.34) ⫽ 0.79,
or eYFP expression in the MeA (Fig. 4L: MeA, F(1,12) ⫽ 1.06, p ⫽
p ⫽ 0.46; degree of freedom is adjusted). On the fifth day, to
0.322;
group ⫻ region, F(2,24) ⫽ 2.74, p ⫽ 0.085) between the ampliconfirm that the increased performance was truly due to the acfied and nonamplified groups. However, there was a trending corretivation of the VGat CeMA-vmPFC projection, mice were tested once
lation between fluorescence intensity of the vmPFC and
more on an FR3 schedule without photostimulation. There were
performance (FR3 ⫹ light active nose poke; Fig. 4M; p ⫽ 0.066), but
still significant differences between the two groups in the number
not
in the comparison with the CeA or MeA fluorescence intensity
of rewards (Fig. 4E; t(30) ⫽ ⫺2.43, p ⫽ 0.02) or active nose pokes
(data are not shown; CeA, p ⫽ 0.853; MeA, p ⫽ 0.963). Together,
(Fig. 4H; t(30) ⫽ ⫺2.40, p ⫽ 0.02), suggesting that activation of
these results suggest that activation of the VGat CeMA-vmPFC projecthis projection was sufficient to produce positive reward learning.
tion is sufficient to modulate external reward value.
However, even though there were significant increases in noseCeMA-vmPFC
poke responses in the VGat
::ChR2 mice on the fourth
day (FR3 ⫹ light), the response distribution showed relatively
VGat CeMA-vmPFC activation does not alter reactivity to sucrose
Studies have shown that midbrain doapminergic systems are inlarge variability (Fig. 4G,I ). This variability in the performance of
the VGat CeMA-vmPFC::ChR2 mice on the fourth day precludes a
volved in reward consumption. For example, activation of
clear answer to whether increased responses in the
GABAergic neurons in the VTA decreased the lick rate in sucroseVGat CeMA-vmPFC::ChR2 mice were due to transient motivational
reward-seeking tasks (van Zessen et al., 2012). In addition,
changes or a persistent behavioral change through the modulation of
previous reports suggested that the CeA is involved in uncondiexternal reward value. Therefore, the VGat CeMA-vmPFC::ChR2 mice
tioned food consumption behaviors (Gosnell, 1988;
were divided into two groups at the median value of the “day 4: FR3
Cai et al., 2014). To assess whether activation of
⫹ light” active nose pokes (median ⫽ 167). The
VGat CeMA-vmPFC::ChR2 also altered reward consumption during
CeMA-vmPFC
the sipper release periods in the sucrose operant conditioning
VGat
::ChR2 mice that nose poked ⬎ 167 times were
categorized as the “amplified” group and the mice that nose poked ⬍
test, we quantified the number of licks during the FR3 ⫹ light
167 times were categorized as the “nonamplified” group (Fig. 4I).
(day 4) and FR3 ⫹ no light (day 5). There was a trend that
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Figure 4. VGat-Cre CeMA-vmPFC::ChR2 terminal activation modulates external reward value. A, Timeline of experimental procedures. Red box: FR1 (day 1), FR3 ⫹ light (days 2– 4), FR3 ⫹ no-light
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VGat CeMA-vmPFC::ChR2 mice consumed more than control mice
during 20 s sipper presentation on the FR3 ⫹ light session, but
this trend was weakened in the absence of photostimulation on
the FR3 ⫹ no-light session (day 5: FR3 ⫹ no light; Fig. 5A; REML:
group, F(1,31.58) ⫽ 4.08, p ⫽ 0.051; day, F(1,30.54) ⫽ 1.03, p ⫽ 0.31;
group ⫻ frequency, F(1, 30.54) ⫽ 1.68, p ⫽ 0.204; degree of freedom was adjusted). To assess more directly whether the photostimulation altered the licking behavior per se, we quantified the
licking rate (licking rate ⫽ total licks/rewards/20 s). No main
effects of group or light or the interaction of group ⫻ light were
detected (Fig. 5B; F ⬍ 1, p ⬎ 0.4), suggesting that
VGat CeMA-vmPFC::ChR2 activation does not alter licking behavior
or generalized reward consumption.
VGat-Cre CeMA-vmPFC::ChR2 terminal photoactivation
facilitates extinction of sucrose-seeking behavior
Our previous experiments suggested that photoactivation of the
VGat CeMA-vmPFC circuit modulates external reward value rather
than being inherently rewarding. Although this implication is
consistent with the result of a recent study showing that CeA
optogenetic activation amplified incentive salience (Robinson et
al., 2014), many studies have also implicated the vmPFC in the
extinction of conditioned behaviors (Peters et al., 2009; Mendoza
et al., 2015). Therefore, we extended our investigation of this
pathway to the role of the VGat-Cre CeMA-vmPFC in extinction of
sucrose operant conditioning.
We tested whether VGat CeMA-vmPFC::ChR2 terminal activation was sufficient to modulate the extinction of sucrose operant
conditioning. Operant responses on the active nose-poke portal
were reinforced on an FR1 schedule with 10% sucrose solution
delivery to the sipper (Fig. 6 A, B). There were no consequences
for responses on the inactive portal. Mice were trained on an FR1
schedule sucrose operant conditioning paradigm for 8 consecutive days without light stimulation. The number of rewards that
mice received and nose pokes were compared throughout the 8 d
of training between the VGat CeMA-vmPFC::ChR2 group and the
control group. There were no main effects of group or group ⫻
4
(Figure legend continued.) of the three groups (Amplified, nonamplified, and control). The
amplified VGat CeMA-vmPFC mice nose poked significantly more than other groups on day 4
(FR3 ⫹ light), but returned to control levels on day 5 (FR3 ⫹ no light). K, Reconstruction of the
approximate locations of the fiber-optic tips. L, Fluorescence intensity in the vmPFC, CeA, and
MeA. M, Scatter graph depicting the relationship between the number of active nose pokes and
vmPFC fluorescence intensity on the FR3 ⫹ light (day 4). *p ⬍ 0.05.

day interactions on received rewards (Fig. 6C; REML: group,
F(1,19) ⫽ 1.96, p ⫽ 0.177; group ⫻ Frequency, F(7,133) ⫽ 0.22, p ⫽
0.979) or active nose pokes (Fig. 6D; REML: group, F(1,19) ⫽ 2.76,
p ⫽ 0.113; group ⫻ frequency, F(7,133) ⫽ 0.04, p ⫽ 1) throughout
training and there was no difference in responses on the inactive
lever (Fig. 6D; F ⬍ 1, n.s.). On the ninth day, mice were tested on
the extinction procedure, wherein responses on the active portal
no longer rewarded 10% sucrose and 20 Hz light stimulation was
delivered throughout the testing session. Control mice showed
increased nose pokes to the active portal compared with the last
day of FR1 training because of the absence of the reward, whereas
VGat CeMA-vmPFC::ChR2 did not show similar changes in the total
number of active nose pokes (Fig. 6 D, E). Post hoc tests confirmed
that control mice nose poked significantly more on the extinction
day than on the last day of the training (Fig. 6E; control, last
training vs extinction: p ⫽ 0.017), but VGat CeMA-vmPFC::ChR2
did not ( p ⫽ 0.473). The latencies to the first visit into the
active nose poke portal were not different between
VGat CeMA-vmPFC::ChR2 mice and control mice (graph is not
shown; t(19) ⫽ ⫺0.98, p ⫽ 0.337), indicating that light stimulation did not change the initial motivation to seek the reward.
During extinction training, nose pokes were reduced more rapidly in VGat CeMA-vmPFC::ChR2 mice than in control mice (Fig. 6F:
extinction; REML: group ⫻ bin, F(5,95) ⫽ 2.81, p ⫽ 0.027). Post
hoc analysis revealed that VGat CeMA-vmPFC::ChR2 mice nose
poked significantly less than control mice in the first 10 min ( p ⬍
0.001), suggesting that VGat CeMA-vmPFC photoactivation facilitates extinction training. On the day after extinction, mice were
retrained in the extinction procedure without stimulation to test
whether the reduction in nose pokes was a transient effect or
long-lasting extinction learning. In the absence of photostimulation, both VGat CeMA-vmPFC::ChR2 and control animals showed
equivalent numbers of nose pokes (Fig. 6D: recall; t(19) ⫽ ⫺0.047,
p ⫽ 0.96). Further analysis with time bins confirmed that the
number of nose pokes decreased similarly between groups
throughout the recall session (Fig. 6F: recall; REML: group,
F(1,44.1) ⫽ 0.17, p ⫽ 0.683; bin, F(5,112.1) ⫽ 7.04, p ⬍ 0.0001;
group ⫻ Bin, F(5,112.1) ⫽ 0.79, p ⫽ 0.562; the degree of freedom
was adjusted). Importantly, there was no change in the number of
nose pokes to the active portal from the last bin of the extinction
day to the first bin of the nose pokes in the recall day (Fig. 6F;
REML: group, F(1, 37.3) ⫽ 0.02, p ⫽ 0.891; bin, F(1,36) ⫽ 3.56, p ⫽
0.066; group ⫻ bin, F(1,36) ⫽ 2.42, p ⫽ 0.128), suggesting that
VGat CeMA-vmPFC::ChR2 activation facilitates extinction learning
of sucrose operant conditioning. Together, these data suggest
that tonic stimulation of the VGat CeMA-vmPFC circuit inhibits the
nose-poke–sucrose association in sucrose extinction training and
reinforces the role of the vmPFC in the extinction process of
appetitive conditioning.

Discussion
In this study, we identified a novel GABAergic projection from
the CeMA to the vmPFC and showed that the photoactivation of
this VGat CeMA-vmPFC circuit drives a preference/reward-related
behavior using RTPP, OFT, and sucrose operant conditioning
behavioral tasks. Photostimulation of VGat CeMA-vmPFC terminals
drove a preference for the photostimulation-paired RTPP side,
indicating that this pathway elicits a positive emotional valence.
Based on this, we explored the role of this VGat CeMA-vmPFC pathway in reward-seeking behavior using a naturally positive reinforcement: sucrose. We demonstrated that the excitation of these
terminals facilitates the extinction of a learned sucrose operant
conditioning and, in the FR3 training, increases the nose-poking
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efforts intensely to receive sucrose rewards. However, photoactivation of these terminals was not sufficient to induce selfstimulation behavior.
These behavioral patterns are consistent with a recent evidence suggesting that the CeA, but not the BLA, is involved in the
amplification of external incentive value without affecting natural intrinsic motivation (Robinson et al., 2014). However, we are
cautious to completely exclude the possibility that photoactivation carries an intrinsically rewarding effect because it was
sufficient to drive RTPP. One possibility is that VGat CeMA-vmPFC
photostimulation has a rewarding effect, but that it is not enough

to drive intrinsic motivation in a more complex behavioral task
that demands higher cognitive processes (exploring a chamber in
RTPP vs nose poking to a specific portal associated with photoactivation). That is, although both exploring and nose poking are
motivationally required actions to receive a reward, operant nose
poking for a reward has more complex stages to be achieved
because it requires relatively unnatural behavior compared with
traveling in a testing box. This complexity makes failing to
form nose-poking self-stimulation more difficult to interpret (Ito
et al., 2005; Ito et al., 2008; Malkki et al., 2010). In fact, whereas
there was a significant preference effect associated with
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VGat CeMA-vmPFC photostimulation in our RTPP test, the effect
size was indeed relatively small compared with other canonical
reward pathway activations (Kim et al., 2013; Al-Hasani et al.,
2015; Namburi et al., 2016; ⬃57% to photostimulation paired
side at 20 Hz). Conversely, exploratory behavior itself can also be
interpreted as an intrinsically rewarding experience. Many
species, including mice, show a natural preference for exploring
novel environments and objects, which implies that the act
of exploration itself has some reward value to the animal
(Mench, 1998a; Mench, 1998b). It is also plausible that the reward from exploring a novel environment was amplified by
VGat CeMA-vmPFC::ChR2 photoactivation and this drove the preference seen in the RTPP test. Also consistent with this possibility,
VGat CeMA-vmPFC::ChR2 mice showed more exploratory behavior
in the OFT experiment, another novel environmental stimulus.
This activity-level change interpretation is not likely to explain
the facilitation of extinction in the sucrose operant conditioning,
however, because mice were already familiarized with the operant
conditioning chambers (Fig. 6C,D). In extinction training, the
groups of mice showed similar latency to the first visit to the
active nose portal and extinction recall performance was equivalent between groups (Fig. 6D). These data support that the
reduction of nose pokes is more likely to reflect facilitation of
extinction learning after nose poking rather than transient motivational changes provoked by contextual cues.
At present, it is not clear whether the VGat CeMA-vmPFC pathway
has a common role in both extinction and acquisition of sucrose
operant conditioning or if the VGat CeMA-vmPFC pathway has a distinct role in each phase of sucrose operant conditioning. One possible explanation is that the VGat CeMA-vmPFC projection may be
involved in the general amplification of associations between response (R; nose poke) and outcome (O; sucrose; Robinson et al.,
2014). For instance, when the nose-poke response results in no reward, VGat CeMA-vmPFC activation amplifies the R-O (nose-poke–no
reward) relationship and facilitates extinction. Alternatively, activation could have changed underlying motivational state of the animal
and thus affected extinction performance. It has been suggested that
the vmPFC plays an overall inhibitory role on behavioral states (e.g.,
inhibit fear, inhibit drug seeking). Because activation of the
VGat CeMA-vmPFC circuit inhibits vmPFC neurons, it is reasonable to
predict an impairment of extinction learning. Instead, we found that
VGat CeMA-vmPFC::ChR2 photoactivation facilitated extinction. The
extinction-facilitating effect was somewhat puzzling, but it may reflect that VGat CeMA-vmPFC activation enhances positive valence state
or increased arousal level, as we found in the RTPP and OFT tests,
and the altered reward-like state may affect extinction behavior. For
example, the enhanced positive state caused by VGat CeMA-vmPFC activation could cause the VGat CeMA-vmPFC::ChR2 mice to increase
reward prediction error and facilitate extinction (Watanabe et al.,
2013). However, these hypotheses require further investigation in
additional studies.
The vmPFC typically has typically been identified as an
inhibitor of learned fear in an aversive Pavlovian conditioning
paradigm. Numerous studies have shown that lesion or pharmacological inactivation of the vmPFC results in an impairment of
extinction learning using Pavlovian fear-conditioning paradigm
(Morgan and LeDoux, 1995; Quirk et al., 2000). Single-unit recording studies have shown that, when vmPFC neurons are responsive to the fear tone during extinction training, animals
show better extinction recall later (Milad and Quirk, 2002). In
addition, electrical/optogenetical stimulation of the vmPFC facilitates the extinction learning, implying that vmPFC is involved in
extinction memory and has an inhibitory role of conditioned fear
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(Milad and Quirk, 2002; Do-Monte et al., 2015). In drug addiction, several studies have suggested that the vmPFC exerts inhibitory drive on drug-seeking behavior (Peters et al., 2009), with
important implications in top-down control for addictive phenotypes. For example, pharmacological inactivation of the
vmPFC results in the relapse (e.g., reinstatement) of extinguished
cocaine-seeking behaviors, although several studies now show
some contradictory results (Peters et al., 2008; LaLumiere et al.,
2012; Van den Oever et al., 2013). The role of the circuit that we
identified in drug addiction models (i.e., self-administration)
and how the dense neuropeptidergic CeMA populations that
project back to the vmPFC are involved remain to be explored.
For example, the role of CeA CRF (McCall et al., 2015) and CeA
dynorphin- opioid-mediated drug-seeking (Al-Hasani et al.,
2015) behaviors would be interesting future avenues of exploring
this pathway.
Furthermore, there are relatively few reports that have evaluated
the role of the vmPFC in the extinction phase of sucrose operant
training, but a recent study showed that infusion of D-cycloserine, a
coagonist at the NMDA receptor, into the vmPFC before sucrose
operant conditioning enhanced extinction memory in rats, consistent with the idea that the vmPFC exerts inhibitory drive on drugseeking behavior (Peters and De Vries, 2013). Given the suggested
inhibitory role of the vmPFC, VGat CeMA-vmPFC::ChR2 photoactivation might be expected to result in an impairment of extinction
learning due to enhanced inhibitory circuit from CeMA to
pyramidal cells in the vmPFC. Instead, we found that
VGat CeMA-vmPFC::ChR2 photoactivation results in the opposite.
This discrepancy may imply that the extinction neural circuits of the
Pavlovian fear conditioning is different from the extinction circuits
of appetitive operant conditioning (Mendoza et al., 2015) or due to
other training protocol differences (e.g., cue light usage in operant
training) or differences in subjects (e.g., rats vs mice). Alternatively,
VGat CeMA-vmPFC::ChR2 activation might inhibit a subpopulation of
vmPFC pyramidal cells that are specifically involved in an appetitive
condition.
We used a VGat-cre transgenic mouse line with AAV5-ChR2
virus to encode light-sensitive cation channel in the CeA. The
virus expressed widely throughout anterior–posterior axis, almost covered the entire the CeA area, and, consistent with other
reports, was not seen in the BLA. However, the ChR2 virus also
spread sparsely into the MeA (Fig. 4L), where many GABAergic
neurons are also present. We were careful to target the CeA based
on well established stereotaxic coordinates in mice (Cai et al.,
2014; McCall et al., 2015); however, this is a technical limitation
due to close proximity and a lack of known molecular markers
that adequately divide these two brain regions and this vmPFC
projection. Therefore, we do not completely exclude projections
from the MeA to vmPFC in the robust behaviors that we observed
in this report given the retrograde labeling to MeA that we show
in Figure 1. The MeA is mostly known to process olfactory information or to control copulatory behavior, which may not be as
closely related to the role of the CeMA–vmPFC inhibitory circuit
as we found here (Canteras et al., 1995; Keshavarzi et al., 2014).
However, further studies are needed to clarify the functional distinction between the CeA- and MeA–vmPFC circuits with more
sophisticated labeling techniques. Therefore, we classified our
projection source as the CeMA, which includes both the CeA and
MeA (Sah et al., 2003), so that follow-up reports can distinguish
these subregions accurately using advanced neuronal markers
(e.g., more selective Cre-driver mice).
It has been documented that the inhibitory role of the vmPFC
in drug-seeking behaviors is mediated by glutamatergic inputs
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from vmPFC to the NA shell (Voorn et al., 2004). The NA shell
sends GABAergic projections to the ventral pallidum, which is
critical for executing motivated behaviors (Peters et al., 2009;
Root et al., 2015). Conversely, a recent study identified a pathway
originating in the infralimbic PFC, one subregion of the vmPFC
that provides tonic inhibition to the VTA. Pharmacological inhibition of this area increases activity of the VTA and is rewarding
to the animal. Similarly, excitation of this area decreases activity
of the VTA and is aversive to the animal (Patton et al., 2013). We
speculate that VGat CeMA-vmPFC::ChR2 activation leads to inhibition of its targets in the vmPFC through GABAergic signaling.
This subpopulation of the vmPFC has been shown previously to
be sufficient for reward behaviors through subsequent disinhibition of VTA dopamine neurons. Therefore, we propose that
activity in this projection mediates incentive salience via a subpopulation inhibition of the vmPFC and disinhibition of the
VTA. In the future, with the use of a genetically encoded calcium
indicator (GCaMP), we may identify which subpopulation(s) of
neurons and ensembles are involved.
The data presented here provide further evidence for involvement of the CeMA in reward behavior, which is of particular
interest because the amygdala has historically been associated
with fear and anxiety behaviors. Furthermore, our data build off
of previous work implicating CeMA circuitry in incentive salience, but we now narrow the investigation down to a single
GABAergic projection to the vmPFC, a structure previously implicated in reward behavior. Moreover, we show evidence for
circuitry typically associated with emotional processing interacting directly with circuitry typically associated with cognitive processing, providing a new angle on the neurobiology of reward
behavior. These results have implications for understanding the
neurobiology of reward, extinction learning, and facilitation of
motivation for rewards and may have important implications in
understanding the neurobiology of drug abuse.
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